TBX3 and cancer: Indeed, whereas knocking down TBX3 in transformed fibroblasts resulted in a more aggressive cancer phenotype, ectopic overexpression of Tbx3, or its splice variant Tbx3+2a, was sufficient to inhibit key features of the cancer phenotype in the aggressive HT1080 cell line.